Journal of International Oncology››2017,Vol. 44››Issue (6): 433-.doi:10.3760/cma.j.issn.1673-422X.2017.06.008
Previous ArticlesNext Articles
Chen Zhipeng, Lu Weidong, Zuo Yun, Zhu Lingjun, Song Yu, Zhou Fang, Zhang Yongqin
Online:
2017-06-08Published:
2017-06-16Contact:
Zuo Yun E-mail:zuoyun1@163.comSupported by:
Zhangjiagang Municipal Science and Technology Infrastructure Program (ZKS1421)
Chen Zhipeng, Lu Weidong, Zuo Yun, Zhu Lingjun, Song Yu, Zhou Fang, Zhang Yongqin. Relationship between APC gene 3′-untranslated region rs1804197 polymorphism and colorectal cancer susceptibility[J]. Journal of International Oncology, 2017, 44(6): 433-.
[1] Herrera L, Kakati S, Gibas L, et al. Gardner syndrome in a man with an interstitial deletion of 5q[J]. Am J Med Genet, 1986, 25(3): 473-476. DOI: 10.1002/ajmg.1320250309. [2] Clevers H, Nusse R. Wnt/βcatenin signaling and disease[J]. Cell, 2012, 149(6): 1192-1205. DOI: 10.1016/j.cell.2012.05.012. [3] 相英花, 杨永耿. 大肠癌的分子基础与临床研究进展[J]. 青海医药杂志, 2003, 33(11): 62-65. DOI: 10.3969/j.issn.10073795.2003.11.040. [4] Lesko AC, Goss KH, Prosperi JR. Exploiting APC function as a novel cancer therapy[J]. Curr Drug Targets, 2014, 15(1): 90-102. [5] Chen FC. Alternative RNA structurecoupled gene regulations in tumorigenesis[J]. Int J Mol Sci, 2014, 16(1): 452-475. DOI: 10.3390/ijms16010452. [6] Kong YW, FerlandMccollough D, Jackson TJ, et al. microRNAs in cancer management[J]. Lancet Oncol, 2012, 13(6): E249-E258. DOI: 10.1016/S14702045(12)700736. [7] Cekaite L, Eide PW, Lind GE, et al. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer[J]. Oncotarget, 2016, 7(6): 6476-6505. DOI: 10.18632/oncotarget.6390. [8] Amirkhah R, Schmitz U, Linnebacher M, et al. MicroRNAmRNA interactions in colorectal cancer and their role in tumor progression[J]. Genes Chromosomes Cancer, 2015, 54(3): 129-141. DOI: 10.1002/gcc.22231. [9] Cipollini M, Landi S, Gemignani F. MicroRNA binding site polymorphisms as biomarkers in cancer management and research[J]. Pharmgenomics Pers Med, 2014, 7(7): 173-191. DOI: 10.2147/PGPM.S61693. [10] Landi D, Gemignani F, Naccarati A, et al. Polymorphisms within microRNAbinding sites and risk of sporadic colorectal cancer[J]. Carcinogenesis, 2008, 29(3): 579-584. DOI: 10.1093/carcin/bgm304. [11] Jia J, Yao P, Arif A, et al. Regulation and dysregulation of 3′UTRmediated translational control[J]. Curr Opin Genet Dev, 2013, 23(1): 29-34. DOI: 10.1016/j.gde.2012.12.004. [12] Vislovukh A, Vargas TR, Polesskaya A, et al. Role of 3′untranslated region translational control in cancer development, diagnostics and treatment[J]. World J Biol Chem, 2014, 5(1): 40-57. DOI: 10.4331/wjbc.v5.i1.40. [13] Zhou XL, Eriksson U, Werelius B, et al. Definition of candidate low risk APC alleles in a Swedish population[J]. Int J Cancer, 2004, 110(4): 550-557. DOI: 10.1002/ijc.20173. |
[1] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[2] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[3] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[4] | Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118. |
[5] | Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong.Expression and clinical significance of ASB6 in colorectal cancer tissues[J]. Journal of International Oncology, 2023, 50(8): 470-474. |
[6] | Chen Zhuo, Tao Jun, Chen Lin, Ke Jing.Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer[J]. Journal of International Oncology, 2023, 50(5): 268-273. |
[7] | Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun.Construction of postoperative prognosis model for patients with colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 157-163. |
[8] | Xu Liangfu, Li Yuanfei.Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 186-190. |
[9] | Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722. |
[10] | Tao Hong, Yin Hong, Luo Hong, Tao Jiayu.Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer[J]. Journal of International Oncology, 2023, 50(11): 683-687. |
[11] | Wang Xi, Wu Chuanqing.Research progress in reversing multidrug resistance in colorectal cancer[J]. Journal of International Oncology, 2023, 50(1): 42-46. |
[12] | Gao Yizhao, Liu Yang, Liu Qiulong, Xing Jinliang.Application of circulating cell-free nucleic acid in clinical diagnosis and treatment of colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 555-559. |
[13] | He Zhefeng, Wu Yiyang, Li Zhenjun, Ying Xiaojiang.Predictive value of inflammatory markers in colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 560-563. |
[14] | Zhao Ying, Zhang Gehong.Study on the correlations between AGR, PLR and NLR changes and chemotherapy efficacy of metastatic colorectal cancer[J]. Journal of International Oncology, 2022, 49(8): 473-477. |
[15] | Huang Mengpan, Wang Xuehong, Lu Yongfu.Mechanism of FOXA2 in colorectal cancer and its application in diagnosis and treatment[J]. Journal of International Oncology, 2022, 49(8): 490-493. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||